Mar Masiá

Universitat de Miguel Hernández d'Elx — Spain

Medicine · Health Sciences

47h-index9.4kcitations316works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV-related health complications and treatments(82), HIV/AIDS drug development and treatment(77), HIV Research and Treatment(71), HIV/AIDS Research and Interventions(60), COVID-19 Clinical Research Studies(29)

Publications292 total

When AI models take the exam: large language models vs medical students on multiple-choice course exams
Medical Education Online·2025Open Access
Impact of Gluteal Injection Site on Pharmacokinetics and Tolerability of Antiretroviral Therapy with Long-Acting Cabotegravir and Rilpivirine
AIDS Patient Care and STDs·2025
Virological Success With Long-Acting Cabotegravir and Rilpivirine Despite Historical Rilpivirine Resistance: A Real-World Case Series
Open Forum Infectious Diseases·2025Open Access
Efficacy and safety of the HIV-1 maturation inhibitor GSK3640254 plus dolutegravir as a two-drug regimen in adults naive to antiretroviral therapy (DYNAMIC): 24-week results from a randomised phase 2b study
EClinicalMedicine·2025· 1 citedOpen Access
A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study)
Journal of Antimicrobial Chemotherapy·2025
A decade of anal cancer screening in the context of HIV care
AIDS·2025
<scp>ADAR1 mRNA</scp> quantification for predicting <scp>HSIL</scp> in persons with <scp>HIV</scp> and abnormal anal cytology
International Journal of Cancer·2025· 1 citedOpen Access
Impact of the initial administration of an antiretroviral drug with latency reversal properties on the HIV reservoir size
Scientific Reports·2025· 3 citedOpen Access
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial
The Lancet HIV·2025· 12 cited
Gut microbiota and weight gain in people with HIV on integrase inhibitors: a five-year longitudinal study
Journal of Antimicrobial Chemotherapy·2025· 1 citedOpen Access
Influence of patient characteristics and oral lead-in on long-acting cabotegravir and rilpivirine pharmacokinetics and outcomes in people with HIV: a real-world study
Antimicrobial Agents and Chemotherapy·2025· 2 citedOpen Access
Low-level viremia linked to virological failure but not clinical events
AIDS·2025
Long-Term Health-Related Quality of Life in People Living with HIV Who Present to Care with AIDS or Severe Immunodeficiency: The CoRIS AIDS Survivors Study
AIDS and Behavior·2025Open Access
Enhanced prediction of thrombotic events in hospitalized COVID-19 patients with soluble thrombomodulin
PLoS ONE·2025· 3 citedOpen Access
Impact of Switching to Long-Acting Injectable Cabotegravir Plus Rilpivirine on Rectal HIV-1 RNA Shedding and Implications for Transmission Risk
The Journal of Infectious Diseases·2025· 1 citedOpen Access
Lung cancer screening in people with HIV: A missed opportunity for better outcomes?
Enfermedades infecciosas y microbiologia clinica (English ed )·2025
P-561. Long-Acting Cabotegravir and Rilpivirine in HIV Individuals Over 60 years: a Real-World Study (RELATIVITY Cohort)
Open Forum Infectious Diseases·2025· 1 citedOpen Access
Thigh Injections of Cabotegravir + Rilpivirine in Virally Suppressed Adults With HIV-1: A Substudy of the Phase 3b ATLAS-2M Study
Clinical Infectious Diseases·2025· 5 citedOpen Access
Lung cancer screening in people with HIV: A missed opportunity for better outcomes?
Enfermedades Infecciosas y Microbiología Clínica·2025
Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks
Journal of Antimicrobial Chemotherapy·2024· 2 citedOpen Access
page 1 of 15Next →

Frequent Co-authors

Félix Gutiérrez(40), Sergio Padilla(29), Ildefonso Hernández‐Aguado(10), Marta Fernández‐González(10), José Alberto García(9), Vanesa Agulló(7), José Ramón Blanco(7), Julia del Amo(7), Pompeyo Viciana(6), Juan Carlos Rodrı́guez(6), Javier García‐Abellán(6), Enrique Bernal(6), José Manuel Ramos(6), Jorge del Romero(5), Christoph Stephan(5), Santiago Moreno(5), Bernardo Soldán(4), Carlos Mirete(4), Gloria Royo(4), Guillermo Telenti(4)